CalciMedica, Inc.: director Guerard Frederic received 20,000 shares

What happened Guerard Frederic, a director of CalciMedica, Inc., was granted an award to acquire 20,000 shares at $0.00 per share, for a total price of $0, reported on Oct 1, 2026. The filing classifies the transaction as a derivative award.

Key details

• Transaction date: Oct 1, 2026; transaction type: grant/award (code A); amount: 20,000 shares; price: $0.00; total: $0.
• Filing date: Oct 5, 2026; period of report: Oct 1, 2026.
• Shares owned after the transaction: not reported in the filing.
• Footnote F1: beginning Aug 19, 2026, 1/12th of the shares subject to the option vest in equal monthly installments over a one year period; the option will be fully vested on the date of the 2027 annual meeting of stockholders.
• The filing does not indicate it was filed late.

Why it may matter

• This was a derivative award (an option grant) subject to the vesting schedule in footnote F1.
• This was not an exercise or a market sale.
• This filing does not show why the insider traded or why the company acted.